In this line, it can be suggested that WP supplementation regardless of RE preserved lean mass by suppressing adverse protein metabolism represented by Atrogin-1, MuRF1, and Bax via the normalization of energy metabolism shown by pAkt/Akt in sarcopenic obesity. The gene discussed is FBXO32; the disease is obesity disorder.